Updates on contrast-induced nephropathy
Presentations available when logged in:
- High dose atorvastatin pre-treatment for preventing contrast-induced nephropathy in patients receiving primary PCI: pre-specified substudy of a pro...
- Urinary liver-type fatty acid-binding protein (L-FABP) predict contrast-induced nephropathy and persistent renal damage after PCI
- Glycosilated hemoglobin levels and the risk of contrast induced nephropathy in non-diabetic patients undergoing coronary angiography or PCI
- Admission hyperglycemia and contrast induced nephropathy